The 2nd Meeting on Epigenetics & Epigenomics will gather some of the most prominent academic speakers in the field, coming from top universities around the world. They will highlight the most recent findings on the mechanisms and physiopathological roles of epigenetic modifications in the development of diseases, including cancer.
 

In addition, industry leaders will present exciting advancements, with opportunities for companies to showcase promising new technologies and therapeutic approaches in the rapidly evolving field of epigenetics and epigenomics. This unique forum will foster collaboration among scientists, pharmaceutical companies, and physicians, providing a platform for innovative ideas and future breakthroughs.